LCN2 and bacterial infectious disease with sepsis: This study demonstrated that the antimicrobial protein Lcn2 protects against CPM-induced cytotoxicity and bacterial sepsis and extends survival in an experimental model of polymicrobial sepsis designed to reproduce the pathophysiologic sequence of events that occurs following cytoablative chemotherapy (Figure 3).